On Wednesday, November 9, investors will grapple with the aftermath of Tuesday's presidential election, while parsing various earnings reports. Mylan (MYL) reports quarterly results after the markets close. Analysts expect earnings of $1.45 a share on sales of $3.12 billion. During the same quarter a year ago, the drug maker reported earnings of $1.43 a share on sales of $2.71 billion. Mylan is the maker of the EpiPen, which came into the spotlight back in August after announcing a 700% price hike for the lifesaving drug. Other notable quarterly reports include Shake Shack (SHAK) , Viacom (VIA) and DISH Network (DISH) . Federal Reserve officials Neel Kashkari and John Williams are expected to deliver remarks at various events on Wednesday. TheStreet's Scott Gamm reports from Wall Street.
More from Video
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money Video Wrap: Apple Rallies as Services Segment Takes Center Stage
There is a lot of Apple news to chew on Wednesday.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.